If you have ocular hypertension, the pressure inside your eye is above normal. Pressure builds because the eye's fluid, known as the aqueous humor, doesn't drain properly. Ocular hypertension ...

Our purpose is to update the comprehensive ophthalmologist about the results of the Ocular Hypertension Treatment Study and the current clinical management of ocular hypertension. In the Ocular ...

Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, it is estimated that 111.8 ...

The majority of our patients with ocular hypertension maintained IOP between 10 and 21 mm Hg across all treatment groups over time. Bai et al [4] also reported successful IOP control in their ...

Bimatoprost is under clinical development by Laboratoires Thea and currently in Phase III for Ocular Hypertension.

According to the company, its Phase 1/2 CLARA trial of AURN001 for corneal edema demonstrated significant dose-dependent ...

and in its product candidate PAXTRAVA™ (travoprost intracameral implant or OTX-TIC), which is currently in a Phase 2 clinical trial for the treatment of open-angle glaucoma or ocular hypertension.

H-1337 is under clinical development by D. Western Therapeutics Institute and currently in Phase II for Open-Angle Glaucoma.

Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.

Ocular’s pipeline also leverages the ELUTYX ... 2 clinical trial for the treatment of open-angle glaucoma or ocular hypertension. Follow Ocular on its website, LinkedIn or X.